[Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics].

A V Anisonyan Yulia Sandler T Y Khaimenova V A Keyan Kirill Saliev Evgeniya Sbikina Elena Vinnitskaya

Published in: Terapevticheskii arkhiv (2020)

All patients with NAFLD in combination with diabetes need screening to detect advanced liver fibrosis: it is advisable to determine the levels of GGTP, haptoglobin and alpha-2-macroglobulin.

Keyphrases

liver fibrosis
glycemic control
type diabetes
cardiovascular disease
cardiovascular risk factors
metabolic syndrome
weight loss